Overexpression of RSPO2, RSPO3, and RSPO4 have been reported in breast tumors, with a particular occurrence in TNBC and being associated with reduced patient survival in case of RSPO2 upregulation [113, 115, 116]. The gene discussed is RSPO2; the disease is breast neoplasm.